Proteomic-based stratification of intermediate-risk prostate cancer patients
Q. Zhong, S. Rui, A. T. Aref, Z. Noor, A. Anees, Y. Zhu, N. Lucas, R. C. Poulos, M. Lyu, T. Zhu, B. Wang, G.-B. Chen, Y. Wang, X. Ding, D. Rutishauser, , P. J. Wild
The paper identifies an 18-protein signature from proteomic data to stratify intermediate-risk prostate cancer patients into low- and high-risk groups for biochemical recurrence.
bioRxiv · Mar 3, 2023Cancer Biology